Matsubara Tokushukai Hospital

Matsubara-shi 580-0032

1 studies enrolling now · 2 studies all time

What they study most

End Stage Kidney Disease, Ischemic Stroke; Ischemic Attack, Transient

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling